The clinical benefits of immune checkpoint inhibitor for thymic carcinomas ∼experience of single public hospital in Japan∼

by Naohiro Uchida, Kohei Fujita, Misato Okamura, Koichi Nakatani, Tadashi Mio
Published 2019-01-01

Afebrile tension pyopneumothorax due to anaerobic bacteria: Fistula or gas production?

by Osamu Kanai, Kohei Fujita, Misato Okamura, Koichi Nakatani, Tadashi Mio
Published 2021-01-01

No need to hesitate: immune‐related neutropenia and thrombocytopenia that improved by corticosteroids

by Osamu Kanai, Koichi Nakatani, Kohei Fujita, Misato Okamura, Tadashi Mio
Published 2021-07-01

Retreatment with anti‐PD‐1 antibody in non‐small cell lung cancer patients previously treated with anti‐PD‐L1 antibody

by Kohei Fujita, Yuki Yamamoto, Osamu Kanai, Misato Okamura, Masayuki Hashimoto, Koichi Nakatani, Satoru Sawai, Tadashi Mio
Published 2020-01-01

Pleural involvement of diffuse large B-cell lymphoma mimicking malignant pleural mesothelioma

by Takanori Ito, Kohei Fujita, Misato Okamura, Yoshiaki Okuno, Zentaro Saito, Osamu Kanai, Koichi Nakatani, Koki Moriyoshi, Tadashi Mio
Published 2020-01-01

Effect of cyclooxygenase inhibitor use on immunotherapy efficacy in non‐small cell lung cancer

by Osamu Kanai, Takanori Ito, Zentaro Saito, Yuki Yamamoto, Kohei Fujita, Misato Okamura, Masayuki Hashimoto, Koichi Nakatani, Satoru Sawai, Tadashi Mio
Published 2021-03-01